基于人工智能的败血症抗生素治疗临床决策支持系统(KINBIOTICS):用例分析。

IF 2.6 Q2 HEALTH CARE SCIENCES & SERVICES
JMIR Human Factors Pub Date : 2025-03-04 DOI:10.2196/66699
Juliane Andrea Düvel, David Lampe, Maren Kirchner, Svenja Elkenkamp, Philipp Cimiano, Christoph Düsing, Hannah Marchi, Sophie Schmiegel, Christiane Fuchs, Simon Claßen, Kirsten-Laura Meier, Rainer Borgstedt, Sebastian Rehberg, Wolfgang Greiner
{"title":"基于人工智能的败血症抗生素治疗临床决策支持系统(KINBIOTICS):用例分析。","authors":"Juliane Andrea Düvel, David Lampe, Maren Kirchner, Svenja Elkenkamp, Philipp Cimiano, Christoph Düsing, Hannah Marchi, Sophie Schmiegel, Christiane Fuchs, Simon Claßen, Kirsten-Laura Meier, Rainer Borgstedt, Sebastian Rehberg, Wolfgang Greiner","doi":"10.2196/66699","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Antimicrobial resistances pose significant challenges in health care systems. Clinical decision support systems (CDSSs) represent a potential strategy for promoting a more targeted and guideline-based use of antibiotics. The integration of artificial intelligence (AI) into these systems has the potential to support physicians in selecting the most effective drug therapy for a given patient.</p><p><strong>Objective: </strong>This study aimed to analyze the feasibility of an AI-based CDSS pilot version for antibiotic therapy in sepsis patients and identify facilitating and inhibiting conditions for its implementation in intensive care medicine.</p><p><strong>Methods: </strong>The evaluation was conducted in 2 steps, using a qualitative methodology. Initially, expert interviews were conducted, in which intensive care physicians were asked to assess the AI-based recommendations for antibiotic therapy in terms of plausibility, layout, and design. Subsequently, focus group interviews were conducted to examine the technology acceptance of the AI-based CDSS. The interviews were anonymized and evaluated using content analysis.</p><p><strong>Results: </strong>In terms of the feasibility, barriers included variability in previous antibiotic administration practices, which affected the predictive ability of AI recommendations, and the increased effort required to justify deviations from these recommendations. Physicians' confidence in accepting or rejecting recommendations depended on their level of professional experience. The ability to re-evaluate CDSS recommendations and an intuitive, user-friendly system design were identified as factors that enhanced acceptance and usability. Overall, barriers included low levels of digitization in clinical practice, limited availability of cross-sectoral data, and negative previous experiences with CDSSs. Conversely, facilitators to CDSS implementation were potential time savings, physicians' openness to adopting new technologies, and positive previous experiences.</p><p><strong>Conclusions: </strong>Early integration of users is beneficial for both the identification of relevant context factors and the further development of an effective CDSS. Overall, the potential of AI-based CDSSs is offset by inhibiting contextual conditions that impede its acceptance and implementation. The advancement of AI-based CDSSs and the mitigation of these inhibiting conditions are crucial for the realization of its full potential.</p>","PeriodicalId":36351,"journal":{"name":"JMIR Human Factors","volume":"12 ","pages":"e66699"},"PeriodicalIF":2.6000,"publicationDate":"2025-03-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11896086/pdf/","citationCount":"0","resultStr":"{\"title\":\"An AI-Based Clinical Decision Support System for Antibiotic Therapy in Sepsis (KINBIOTICS): Use Case Analysis.\",\"authors\":\"Juliane Andrea Düvel, David Lampe, Maren Kirchner, Svenja Elkenkamp, Philipp Cimiano, Christoph Düsing, Hannah Marchi, Sophie Schmiegel, Christiane Fuchs, Simon Claßen, Kirsten-Laura Meier, Rainer Borgstedt, Sebastian Rehberg, Wolfgang Greiner\",\"doi\":\"10.2196/66699\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Antimicrobial resistances pose significant challenges in health care systems. Clinical decision support systems (CDSSs) represent a potential strategy for promoting a more targeted and guideline-based use of antibiotics. The integration of artificial intelligence (AI) into these systems has the potential to support physicians in selecting the most effective drug therapy for a given patient.</p><p><strong>Objective: </strong>This study aimed to analyze the feasibility of an AI-based CDSS pilot version for antibiotic therapy in sepsis patients and identify facilitating and inhibiting conditions for its implementation in intensive care medicine.</p><p><strong>Methods: </strong>The evaluation was conducted in 2 steps, using a qualitative methodology. Initially, expert interviews were conducted, in which intensive care physicians were asked to assess the AI-based recommendations for antibiotic therapy in terms of plausibility, layout, and design. Subsequently, focus group interviews were conducted to examine the technology acceptance of the AI-based CDSS. The interviews were anonymized and evaluated using content analysis.</p><p><strong>Results: </strong>In terms of the feasibility, barriers included variability in previous antibiotic administration practices, which affected the predictive ability of AI recommendations, and the increased effort required to justify deviations from these recommendations. Physicians' confidence in accepting or rejecting recommendations depended on their level of professional experience. The ability to re-evaluate CDSS recommendations and an intuitive, user-friendly system design were identified as factors that enhanced acceptance and usability. Overall, barriers included low levels of digitization in clinical practice, limited availability of cross-sectoral data, and negative previous experiences with CDSSs. Conversely, facilitators to CDSS implementation were potential time savings, physicians' openness to adopting new technologies, and positive previous experiences.</p><p><strong>Conclusions: </strong>Early integration of users is beneficial for both the identification of relevant context factors and the further development of an effective CDSS. Overall, the potential of AI-based CDSSs is offset by inhibiting contextual conditions that impede its acceptance and implementation. The advancement of AI-based CDSSs and the mitigation of these inhibiting conditions are crucial for the realization of its full potential.</p>\",\"PeriodicalId\":36351,\"journal\":{\"name\":\"JMIR Human Factors\",\"volume\":\"12 \",\"pages\":\"e66699\"},\"PeriodicalIF\":2.6000,\"publicationDate\":\"2025-03-04\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11896086/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"JMIR Human Factors\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.2196/66699\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"HEALTH CARE SCIENCES & SERVICES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"JMIR Human Factors","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2196/66699","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
引用次数: 0

摘要

背景:抗菌素耐药性对卫生保健系统构成重大挑战。临床决策支持系统(cdss)代表了促进更有针对性和基于指南的抗生素使用的潜在策略。将人工智能(AI)集成到这些系统中,有可能支持医生为特定患者选择最有效的药物治疗。目的:本研究旨在分析基于人工智能的CDSS试点版本用于脓毒症患者抗生素治疗的可行性,并确定其在重症监护医学中实施的促进和抑制条件。方法:采用定性方法,分2个步骤进行评价。最初,进行了专家访谈,其中要求重症监护医生从可行性、布局和设计方面评估基于人工智能的抗生素治疗建议。随后,进行焦点小组访谈,以检验基于人工智能的CDSS的技术接受程度。访谈是匿名的,并使用内容分析进行评估。结果:就可行性而言,障碍包括以前抗生素给药实践的可变性,这影响了人工智能建议的预测能力,并且需要更多的努力来证明这些建议的偏差。医生接受或拒绝建议的信心取决于他们的专业经验水平。重新评估CDSS建议的能力和直观、用户友好的系统设计被认为是提高接受度和可用性的因素。总的来说,障碍包括临床实践中的数字化水平低,跨部门数据的可用性有限,以及以往cdss的负面经验。相反,CDSS实施的促进因素是潜在的时间节省,医生对采用新技术的开放态度,以及积极的以往经验。结论:用户的早期整合有利于识别相关背景因素和进一步开发有效的CDSS。总的来说,基于人工智能的cdss的潜力被阻碍其接受和实施的环境条件所抵消。基于人工智能的cdss的发展和这些抑制条件的缓解对于充分发挥其潜力至关重要。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
An AI-Based Clinical Decision Support System for Antibiotic Therapy in Sepsis (KINBIOTICS): Use Case Analysis.

Background: Antimicrobial resistances pose significant challenges in health care systems. Clinical decision support systems (CDSSs) represent a potential strategy for promoting a more targeted and guideline-based use of antibiotics. The integration of artificial intelligence (AI) into these systems has the potential to support physicians in selecting the most effective drug therapy for a given patient.

Objective: This study aimed to analyze the feasibility of an AI-based CDSS pilot version for antibiotic therapy in sepsis patients and identify facilitating and inhibiting conditions for its implementation in intensive care medicine.

Methods: The evaluation was conducted in 2 steps, using a qualitative methodology. Initially, expert interviews were conducted, in which intensive care physicians were asked to assess the AI-based recommendations for antibiotic therapy in terms of plausibility, layout, and design. Subsequently, focus group interviews were conducted to examine the technology acceptance of the AI-based CDSS. The interviews were anonymized and evaluated using content analysis.

Results: In terms of the feasibility, barriers included variability in previous antibiotic administration practices, which affected the predictive ability of AI recommendations, and the increased effort required to justify deviations from these recommendations. Physicians' confidence in accepting or rejecting recommendations depended on their level of professional experience. The ability to re-evaluate CDSS recommendations and an intuitive, user-friendly system design were identified as factors that enhanced acceptance and usability. Overall, barriers included low levels of digitization in clinical practice, limited availability of cross-sectoral data, and negative previous experiences with CDSSs. Conversely, facilitators to CDSS implementation were potential time savings, physicians' openness to adopting new technologies, and positive previous experiences.

Conclusions: Early integration of users is beneficial for both the identification of relevant context factors and the further development of an effective CDSS. Overall, the potential of AI-based CDSSs is offset by inhibiting contextual conditions that impede its acceptance and implementation. The advancement of AI-based CDSSs and the mitigation of these inhibiting conditions are crucial for the realization of its full potential.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
JMIR Human Factors
JMIR Human Factors Medicine-Health Informatics
CiteScore
3.40
自引率
3.70%
发文量
123
审稿时长
12 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信